Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AZD3988
Cat. No.:
OB0425LY-255
Appearance:
Solid
Purity:
99.83%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
AZD3988 is a selective inhibitor that targets a specific protein kinase with apoptosis-promoting properties.
Synonyms:
892489-52-0; AZD-3988; AZD 3988; Trans-4-[4-[[[5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl]amino]phenyl]cyclohexaneacetic acid; Trans-4-[4-[[[5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl]amino]phenyl]-cyclohexaneacetic acid
CAS No.:
892489-52-0
Compound CID:
23648867
Formula:
C23H22F2N4O4
Formula Weight:
456.44
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
AZD3988 can be use as an acyl transferase-1 (DGAT-1) inhibitor for metabolic diseases.
